Journal for ImmunoTherapy of Cancer (Nov 2023)

442-G Metabolic reprogramming regulates anti-tumor effects of engineered CAR/TCR T cells

Xiaoyu Zhang,
Yama Abassi,
Rashmi Pillai

Affiliations

Xiaoyu Zhang: Agilent Technologies, San Diego, CA, USA
Yama Abassi: Agilent Technologies, San Diego, CA, USA
Rashmi Pillai: Agilent Technologies, San Diego, CA, USA

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0442-G
Journal volume & issue: Vol. 11, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal